May 2024 – Page 6

Semaglutide Significantly Improves Cardiovascular Health and Reduces Mortality Risk in Kidney Disease Patients, Novo Reports

1 year ago talkbio0Tagged Cardiovascular system, Clinical Trials, Health, Mortality Vital Statistics, Novo, semaglutide

Semaglutide, Novo, cardiovascular health, kidney disease, mortality risk, clinical trial

J&J Adjusts Dosing Strategy for Actinium Prostate Cancer Drug Following Early Study Setbacks

1 year ago talkbio0Tagged Actinium, Cancer Therapeutic Procedure, Cessation of life, Clinical Trials, dosing, Drug Development, Flexible, J&J, Johnson & Johnson, Malignant neoplasm of prostate

J&J, Johnson & Johnson, actinium prostate cancer drug, capped dosing, flexible dosing, patient deaths, early study, clinical trial, cancer treatment, drug development.

ASCO24: Nimbus Unveils Promising Early Data for Next-Generation HPK1 Blocker in IO Therapies

1 year ago talkbio0Tagged ASCO24, Blocker, Clinical Trials, immuno-oncology, Malignant Neoplasms, MAP4K1 gene, Next-Generation IO Therapies, Nimbus

ASCO24, Nimbus, Next-Generation IO Therapies, HPK1 Blocker, Early Data, Cancer Treatment, Immuno-Oncology, Clinical Trials.

Exscientia Streamlines Operations, Prioritizes AI-Driven Drug Discovery

1 year ago talkbio0Tagged AI-generated pipeline, Biotechnology, Drug Discovery, Drug Industry, Efficiency, Exscientia, operational, Staff

Exscientia, AI-generated pipeline, drug discovery, staff reduction, operational efficiency, biotechnology, pharmaceutical industry

Pfizer’s Continuous Cost-Cutting: A $4B Savings Drive Extended to 2027

1 year ago talkbio0Tagged cost-cutting, Drug Industry, Efficiency, Financial savings, Pfizer, profitability, restructuring

Pfizer, cost-cutting, savings drive, 2027, pharmaceutical industry, restructuring, efficiency, profitability.

Bicycle Therapeutics Gears Up for Future Milestones with $555 Million Capital Infusion

1 year ago talkbio0Tagged Bicycle, Biotechnology, Capital, Catalyst, Clinical Trials, Drug Development, Infusion procedures, investors, milestones

Bicycle Therapeutics, funding, catalysts, biotechnology, drug development, clinical trials, investors, capital infusion, milestones.

Takeda Ventures into Molecular Glue Degraders with Degron Collaboration

1 year ago talkbio0Tagged Degron, Drug Discovery, molecular glue, pharmaceutical collaboration, Protein Degradation, Metabolic, Takeda

Takeda, Degron, molecular glue degraders, pharmaceutical collaboration, targeted protein degradation, drug discovery.

Tango Pauses Clinical Trials of Promising Solid Tumor Treatment Due to Liver Toxicity Concerns

1 year ago talkbio0Tagged ARNT gene, aspects of adverse effects, Cancer Research, Clinical Trials, Drug Development, Liver, solid tumor treatment, Toxicity aspects

Tango Therapeutics, solid tumor treatment, clinical trials, liver toxicity, drug development, cancer research, treatment side effects, patient safety.